Active

NS PHARMA

Switched

BE0822653238

Rechtspersoon Private limited company 1 establishment

Rue d'Auvelais(ARS) 43, 5060 Sambreville Detailhandel in farmaceutische producten

Active for

16 year, 7 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 215,691

▼ 6% vs 2024

Profit

Healthy

€ 35,970

▼ 15% vs 2024

Debts

Low

€ 422,295

▼ 2% vs 2024

NS PHARMA from Sambreville, company number BE0822653238, closed financial year 2025 with a result of € 35,970 after tax. For that financial year NS PHARMA recorded a gross margin of € 215,691 and equity of € 269,360. Compared with financial year 2024, the result moved from € 42,261 to € 35,970. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 2, 2026.

What happened at NS PHARMA?

What happened at NS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 35,970 (▼ 15% vs 2024). filed late Source: NBB ↗
  • New establishment in Sambreville. KBO
  • Start of the company according to the CBE. KBO

In short

From € 46,089 profit in 2022 to € 35,970 profit in 2025.

Paid € 73,337 in corporate taxes since 2022.

Best year ever: 2023, with € 55,753 profit.

On average € 191,600 of value added per employee in 2024.

A new publication or filing at NS PHARMA? We notify you, reason included.

Follow NS PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

NATHALIE (ARSIMONT) SEVERIN
NS PHARMA

Behind NS PHARMA is NATHALIE (ARSIMONT) SEVERIN.

See the full network in the app

Directors

According to the 2025 annual accounts

NATHALIE (ARSIMONT) SEVERIN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue d'Auvelais(ARS) 43 box B

5060 Sambreville

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0822.653.238
VAT number
BE 0822.653.238
Registered office
Rue d'Auvelais(ARS) 43 bus B, 5060 Sambreville
Names & denominations
NS PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
27 January 2010
Peppol
Active · Active since 18 Dec 2025
Activities · NACE

Detailhandel in farmaceutische producten

Frequently asked questions

What is the enterprise number of NS PHARMA?
The enterprise number of NS PHARMA is BE0822653238.
What is the address of NS PHARMA?
The registered office of NS PHARMA is located at Rue d'Auvelais(ARS) 43 box B, 5060 Sambreville.
When was NS PHARMA founded?
NS PHARMA was founded on 27 January 2010.
What is the main activity of NS PHARMA?
The main activity of NS PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does NS PHARMA have a website?
No website is currently known for NS PHARMA.
How much profit did NS PHARMA make in 2025?
NS PHARMA posted a profit after taxes of € 35,970 in financial year 2025.
What is the revenue of NS PHARMA?
As a small company, NS PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 215,691.
Where can I find the annual accounts of NS PHARMA?
NS PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of NS PHARMA?
According to the 2025 annual accounts, the directors of NS PHARMA are: NATHALIE (ARSIMONT) SEVERIN.
Who owns NS PHARMA?
Behind NS PHARMA is NATHALIE (ARSIMONT) SEVERIN.